Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aethlon Medical, Inc.
Cancer Treatment Application of the Aethlon Hemopurifier Published in Journal of Translational Medicine
August 15th, 2008
Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that a peer reviewed scientific paper coauthored by Aethlon researchers has been published in the Journal of Translational Medicine. The paper entitled, "Exosomes as a Tumor Immune Escape Mechanism: Possible Therapeutic Implications" discusses the mechanism by which exosomes released by cancerous tumors are able to kill off immune cells in cancer patients. The paper further discusses the novel therapeutic approach of the Aethlon Hemopurifier(R) to capture and inhibit the spread of such immunosuppressive exosomes in cancer patients. The abstract and complete article are available to be accessed online at:...
Source: Health Business Week (2008-08-15)
|
|
Advertisement |
|
|
|
